Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy
Cardiopulmonary Exercise Testing as a Diagnostic Tool and a Quantitative Measure of Post-exertional Malaise in Myalgic Encephalopathy/Chronic Fatigue Syndrome
1 other identifier
observational
33
1 country
1
Brief Summary
Circumstantial evidence suggests that patients diagnosed with myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) perform worse on day 2 in a 2-day consecutive cardiopulmonary exercise test (CPET). The aim of this study is to examine if CPET can distinguish between ME/CFS patients and healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 14, 2016
CompletedFirst Posted
Study publicly available on registry
November 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedNovember 4, 2020
November 1, 2020
4.8 years
November 14, 2016
November 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximal oxygen uptake
Measurement of oxygen uptake during ergometer cycling
At 48 hour
Secondary Outcomes (4)
Lactate accumulation
At 48 hour
Cytokine profile
At 48 hour
Immunophenotyping
At 48 hour
Cardiac status
At 48 hour
Study Arms (3)
ME/CFS group
Patients with a verified diagnosis of ME/CFS according to the Canada criteria
Fatigue group
Patients with fatigue, but not ME/CFS
Control group
Healthy control persons
Interventions
A 2-day consecutive testing on an ergometer cycle
Eligibility Criteria
1. Patients with ME/CFS 2. Patients with fatigue but not ME/CFS 3. Healthy controls
You may qualify if:
- Diagnosed with ME/CFS according to the Canadian and Fukuda criteria; miid to moderately affected)
- Provide written consent
- Able to perform the test
You may not qualify if:
- Not provided written consent
- Unable to perform the test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oslolead
- The Glittre Cliniccollaborator
- Oslo University Hospitalcollaborator
Study Sites (1)
Glittre Clinic
Hakadal, Norway
Biospecimen
Whole blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Per O Iversen, MD
University of Oslo
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 14, 2016
First Posted
November 21, 2016
Study Start
June 1, 2014
Primary Completion
April 1, 2019
Study Completion
November 1, 2020
Last Updated
November 4, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share